Trial Details

COMPLETED
Basic Information
Clinical ID c3400
Identifier NCT02111603
Trial Title Ability of Mayo Clinic High-performance Liquid Chromatography (HPLC) Method to Measure Fecal Bile Acids
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Diarrhea Predominant Irritable Bowel Syndrome
Interventions DRUG: Colesevelam
Participant Information
Sponsor Mayo Clinic
City Rochester
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2014-04
Primary Completion Date 2014-08
Completion Date 2015-09